Gene · 6362
Papers4,584
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 4,584
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of Macrophages and Alveolar Epithelial Cells in the Development of ARDS. | Inflammation | 2023 | 36048270 | PubTator, text mining | PubMed |
| Macrophages as determinants and regulators of fibrosis in systemic sclerosis. | Rheumatology (Oxford) | 2023 | 35861385 | PubTator, text mining | PubMed |
| Clinical and molecular change induced by repeated low-dose visible light exposure in both light-skinned and dark-skinned individuals. | Photodermatol Photoimmunol Photomed | 2023 | 35861041 | PubTator, text mining | PubMed |
| A comprehensive network map of IL-17A signaling pathway. | J Cell Commun Signal | 2023 | 35838944 | PubTator, text mining | PubMed |
| Regulation of intrinsic and extrinsic metabolic pathways in tumour-associated macrophages. | FEBS J | 2023 | 35486022 | PubTator, text mining | PubMed |
| Oral Mucosal In Vitro Cell Culture Model to Study the Effect of Fructilactobacillus Phage on the Interplay between Food Components and Oral Microbiota. | Endocr Metab Immune Disord Drug Targets | 2023 | 35400331 | PubTator, text mining | PubMed |
| Properties and fate of human mesenchymal stem cells upon miRNA let-7f-promoted recruitment to atherosclerotic plaques. | Cardiovasc Res | 2023 | 35238350 | PubTator, text mining | PubMed |
| Therapeutic Approaches to Systemic Sclerosis: Recent Approvals and Future Candidate Therapies. | Clin Rev Allergy Immunol | 2023 | 34468946 | PubTator, text mining | PubMed |
| Tumor hijacks macrophages and microbiota through extracellular vesicles. | Exploration (Beijing) | 2022 | 37324578 | PubTator, text mining | PubMed |
| CD47-blocking Antibody ZL-1201 Promotes Tumor-associated Macrophage Phagocytic Activity and Enhances the Efficacy of the Therapeutic Antibodies and Chemotherapy. | Cancer Res Commun | 2022 | 36970051 | PubTator, text mining | PubMed |
| Joint Secondary Transcriptomic Analysis of Non-Hodgkin's B-Cell Lymphomas Predicts Reliance on Pathways Associated with the Extracellular Matrix and Robust Diagnostic Biomarkers. | J Bioinform Syst Biol | 2022 | 36873459 | PubTator, text mining | PubMed |
| Clinical adoptive regulatory T Cell therapy: State of the art, challenges, and prospective. | Front Cell Dev Biol | 2022 | 36794233 | PubTator, text mining | PubMed |
| Immunotherapy and tumor mutational burden in cancer patients with liver metastases: A meta and real word cohort analysis. | Front Oncol | 2022 | 36741738 | PubTator, text mining | PubMed |
| Innate immunity in pancreatic cancer: Lineage tracing and function. | Front Immunol | 2022 | 36726981 | PubTator, text mining | PubMed |
| Harnessing the immune system in the treatment of cutaneous T cell lymphomas. | Front Oncol | 2022 | 36713518 | PubTator, text mining | PubMed |
| The roles of chemokines following intracerebral hemorrhage in animal models and humans. | Front Mol Neurosci | 2022 | 36704330 | PubTator, text mining | PubMed |
| Pre-clinical models for evaluating glioma targeted immunotherapies. | Front Immunol | 2022 | 36700223 | PubTator, text mining | PubMed |
| Epigenetic modifications in chronic rhinosinusitis with and without nasal polyps. | Front Genet | 2022 | 36699454 | PubTator, text mining | PubMed |
| A novel pyroptosis scoring model was associated with the prognosis and immune microenvironment of esophageal squamous cell carcinoma. | Front Genet | 2022 | 36685978 | PubTator, text mining | PubMed |
| Fc gamma receptor IIb in tumor-associated macrophages and dendritic cells drives poor prognosis of recurrent glioblastoma through immune-associated signaling pathways. | Front Genet | 2022 | 36685974 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6362/papers?page=48